Toshiki Okubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Toshiki Okubo has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Narihito Nagoshi
Keio University School of Medicine
43 shared publications - Kota Watanabe
Keio University School of Medicine
41 shared publications Morio Matsumoto
Keio University School of Medicine
36 shared publicationsMasaya Nakamura
Keio University School of Medicine
33 shared publicationsSatoshi Suzuki
Keio University School of Medicine
33 shared publicationsMasahiro Ozaki
Keio University School of Medicine
22 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by SAGE Publications in Global Spine Journal
Response to the Letter to the Editor Regarding “Does Surgeon Experience Influence Surgical Safety and Patient Satisfaction After Anterior Cervical Discectomy and Fusion? A Prospective Multicenter Comparison Study Between Non-Board-Certified and Board-Certified Spine Surgeons”
- 20 October 2026
- Published by SAGE Publications in Global Spine Journal
Open AccessResponse to the Letter to the Editor Regarding “Does Surgeon Experience Influence Surgical Safety and Patient Satisfaction After Anterior Cervical Discectomy and Fusion? A Prospective Multicenter Comparison Study Between Non-Board-Certified and Board-Certified Spine Surgeons”
- 18 September 2026
- Published by Springer Nature in Spinal Cord
- Vol. 64 (10) , 921-928
Predictive factors for postoperative motor recovery of proximal upper extremity in patients with degenerative cervical myelopathy: a multicenter prospective study
Study design Multicenter prospective study. Objective To clarify the postoperative course and predictive factors for motor recovery of the proximal upper extremity in patients with degenerative cervical myelopathy (DCM). Setting Keio University School of Medicine and affiliated hospitals belonging to Keio Spine Research Group (KSRG). Methods From a total of 1322 patients undergoing surgery for DCM, 363 patients with preoperative weakness in the deltoid or biceps brachii were included. Patients were divided into two groups based on their status at 2 years postoperatively: P group (persistent weakness; n = 131) and C group (complete recovery; n = 232). Variables including age, sex, medical history, duration of symptoms, surgical procedure, radiographic parameters, Japanese Otrhopaedic Association (JOA) scores, JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ), SF-36, and pain scales were compared. Results P group was significantly older and had higher rates of hypertension, cerebrovascular disease, other musculoskeletal diseases, and prior cervical surgery. Preoperative JOA scores for upper extremity motor function were also significantly lower in P group (p < 0.05). Multivariate logistic regression analysis identified lower preoperative JOA motor scores (OR 3.27), prior cervical surgery (OR 3.29), history of other musculoskeletal diseases (OR 1.77), and history of hypertension (OR 1.64) as significant predictors of poor prognosis (p < 0.05). Conclusion Surgical interventions are effective for motor recovery, with over 60% of patients achieving full strength. However, preoperative motor severity, prior surgery, history of other musculoskeletal diseases, and history of hypertension are key predictors of limited improvement. Level of evidence Level II.
- 18 September 2026
- Published by Springer Nature in Spinal Cord
- Vol. 64 (10) , 921-928
Predictive factors for postoperative motor recovery of proximal upper extremity in patients with degenerative cervical myelopathy: a multicenter prospective study
Study design Multicenter prospective study. Objective To clarify the postoperative course and predictive factors for motor recovery of the proximal upper extremity in patients with degenerative cervical myelopathy (DCM). Setting Keio University School of Medicine and affiliated hospitals belonging to Keio Spine Research Group (KSRG). Methods From a total of 1322 patients undergoing surgery for DCM, 363 patients with preoperative weakness in the deltoid or biceps brachii were included. Patients were divided into two groups based on their status at 2 years postoperatively: P group (persistent weakness; n = 131) and C group (complete recovery; n = 232). Variables including age, sex, medical history, duration of symptoms, surgical procedure, radiographic parameters, Japanese Otrhopaedic Association (JOA) scores, JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ), SF-36, and pain scales were compared. Results P group was significantly older and had higher rates of hypertension, cerebrovascular disease, other musculoskeletal diseases, and prior cervical surgery. Preoperative JOA scores for upper extremity motor function were also significantly lower in P group (p < 0.05). Multivariate logistic regression analysis identified lower preoperative JOA motor scores (OR 3.27), prior cervical surgery (OR 3.29), history of other musculoskeletal diseases (OR 1.77), and history of hypertension (OR 1.64) as significant predictors of poor prognosis (p < 0.05). Conclusion Surgical interventions are effective for motor recovery, with over 60% of patients achieving full strength. However, preoperative motor severity, prior surgery, history of other musculoskeletal diseases, and history of hypertension are key predictors of limited improvement. Level of evidence Level II.
- 4 September 2026
- Published by Springer Nature in Spinal Cord
- Vol. 64 (11) , 1026-1031
Association between the number of fused levels and surgical outcomes following posterior cervical fusion for degenerative cervical myelopathy
Study Design Prospective multicenter cohort study. Objectives To evaluate the association between the number of fused levels and clinical outcomes following posterior cervical fusion for degenerative cervical myelopathy (DCM). Setting Multicenter registry study in Japan. Methods Data from a prospective multicenter cervical spine surgery registry were analyzed. Seventy-seven patients with DCM who underwent posterior cervical fusion and completed 2-year follow-up were included. Patients were stratified by the number of fused levels: 1 level (n = 27), 2–3 levels (n = 34), and ≥4 levels (n = 16). Clinical outcomes included cervical JOA score, VAS, SF-36, NPSI, and JOACMEQ. Cervical alignment and range of motion were radiographically evaluated. Results Cervical alignment was similar among groups, whereas postoperative cervical ROM was significantly reduced in the ≥4-level group (p = 0.011). No significant differences were observed in JOA, SF-36, NPSI, or VAS outcomes. However, a lower JOACMEQ cervical function effectiveness rate was observed in groups with more fusion levels (p = 0.004). Perioperative complication rates were comparable across groups. Conclusion Although a greater number of fused levels was associated with reduced patient-perceived cervical function, no significant between-group differences were observed in neurological recovery, pain relief, or overall quality of life. These findings support preoperative counselling regarding postoperative cervical function when multilevel fusion is clinically indicated. However, because fusion length was determined according to clinical indications in this observational study, residual confounding by indication cannot be excluded, and the findings should be interpreted cautiously.
- 4 September 2026
- Published by Springer Nature in Spinal Cord
- Vol. 64 (11) , 1026-1031
Association between the number of fused levels and surgical outcomes following posterior cervical fusion for degenerative cervical myelopathy
Study Design Prospective multicenter cohort study. Objectives To evaluate the association between the number of fused levels and clinical outcomes following posterior cervical fusion for degenerative cervical myelopathy (DCM). Setting Multicenter registry study in Japan. Methods Data from a prospective multicenter cervical spine surgery registry were analyzed. Seventy-seven patients with DCM who underwent posterior cervical fusion and completed 2-year follow-up were included. Patients were stratified by the number of fused levels: 1 level (n = 27), 2–3 levels (n = 34), and ≥4 levels (n = 16). Clinical outcomes included cervical JOA score, VAS, SF-36, NPSI, and JOACMEQ. Cervical alignment and range of motion were radiographically evaluated. Results Cervical alignment was similar among groups, whereas postoperative cervical ROM was significantly reduced in the ≥4-level group (p = 0.011). No significant differences were observed in JOA, SF-36, NPSI, or VAS outcomes. However, a lower JOACMEQ cervical function effectiveness rate was observed in groups with more fusion levels (p = 0.004). Perioperative complication rates were comparable across groups. Conclusion Although a greater number of fused levels was associated with reduced patient-perceived cervical function, no significant between-group differences were observed in neurological recovery, pain relief, or overall quality of life. These findings support preoperative counselling regarding postoperative cervical function when multilevel fusion is clinically indicated. However, because fusion length was determined according to clinical indications in this observational study, residual confounding by indication cannot be excluded, and the findings should be interpreted cautiously.
- Open Access
- 3 September 2026
- Published by SAGE Publications in Global Spine Journal
Characteristics of Patients Achieving Clinically Meaningful Improvement in Neuropathic Pain After Surgery for Degenerative Cervical Myelopathy
Study Design: Retrospective analysis of a prospectively maintained multicenter cohort. Objectives: To identify clinical characteristics associated with clinically meaningful improvement in neuropathic pain and to evaluate its relationship with postoperative functional outcomes in patients with degenerative cervical myelopathy (DCM). Methods: Among 816 patients with complete Neuropathic Pain Symptom Inventory (NPSI) data, 597 with baseline total NPSI scores ≥7 were included in the primary analysis because they were eligible to achieve the predefined minimal clinically important difference (MCID) of a 7-point reduction. Patients were classified as responders or non-responders according to MCID achievement at 2 years postoperatively. Clinical outcomes included the cervical Japanese Orthopaedic Association (JOA) score, visual analog scale (VAS), Short Form-36 (SF-36), and JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ). Results: Of the 597 patients, 323 (54.1%) achieved the NPSI MCID. Responders had significantly higher preoperative total NPSI scores than non-responders, whereas no significant differences were observed in baseline JOA, VAS, or SF-36 scores. Responders demonstrated greater improvement in upper-extremity pain and numbness and in the SF-36 mental component summary score. They also showed significantly higher effectiveness rates in the upper-extremity, lower-extremity, bladder, and quality-of-life domains of the JOACMEQ. Conclusions: Clinically meaningful improvement in neuropathic pain after surgery for DCM was associated with broader postoperative recovery across pain-related, functional, mental health, and quality-of-life outcomes. Assessment of neuropathic pain may provide clinically relevant information complementary to conventional measures of neurological function.
- 3 September 2026
- Published by SAGE Publications in Global Spine Journal
Open AccessCharacteristics of Patients Achieving Clinically Meaningful Improvement in Neuropathic Pain After Surgery for Degenerative Cervical Myelopathy
Study Design: Retrospective analysis of a prospectively maintained multicenter cohort. Objectives: To identify clinical characteristics associated with clinically meaningful improvement in neuropathic pain and to evaluate its relationship with postoperative functional outcomes in patients with degenerative cervical myelopathy (DCM). Methods: Among 816 patients with complete Neuropathic Pain Symptom Inventory (NPSI) data, 597 with baseline total NPSI scores ≥7 were included in the primary analysis because they were eligible to achieve the predefined minimal clinically important difference (MCID) of a 7-point reduction. Patients were classified as responders or non-responders according to MCID achievement at 2 years postoperatively. Clinical outcomes included the cervical Japanese Orthopaedic Association (JOA) score, visual analog scale (VAS), Short Form-36 (SF-36), and JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ). Results: Of the 597 patients, 323 (54.1%) achieved the NPSI MCID. Responders had significantly higher preoperative total NPSI scores than non-responders, whereas no significant differences were observed in baseline JOA, VAS, or SF-36 scores. Responders demonstrated greater improvement in upper-extremity pain and numbness and in the SF-36 mental component summary score. They also showed significantly higher effectiveness rates in the upper-extremity, lower-extremity, bladder, and quality-of-life domains of the JOACMEQ. Conclusions: Clinically meaningful improvement in neuropathic pain after surgery for DCM was associated with broader postoperative recovery across pain-related, functional, mental health, and quality-of-life outcomes. Assessment of neuropathic pain may provide clinically relevant information complementary to conventional measures of neurological function.
- 1 September 2026
- Published by Wolters Kluwer Health in Spine
Predictors of Residual Neck/Shoulder Symptom Following Surgery for Degenerative Cervical Myelopathy
Study Design: Prospective multicenter cohort study. Objective: To determine the prevalence of residual neck/shoulder pain or stiffness after surgery for degenerative cervical myelopathy (DCM) and identify the factors associated with the persistence of these symptoms. Summary of Background Data: Neck/shoulder pain or stiffness is common in patients with DCM and may persist despite surgical treatment. However, the factors associated with the persistence of these symptoms remain unclear. Methods: A total of 612 patients with preoperative neck/shoulder pain or stiffness who underwent surgery for DCM were included in this study. Residual neck/shoulder symptoms were defined as a visual analog scale (VAS) score of > 30 mm at 2 years after surgery. Demographic characteristics, radiographic findings, surgical variables, neurological function, and patient-reported outcome measures were compared between patients with and without residual neck/shoulder symptoms. Binary logistic regression analysis was performed to identify the independent predictors of residual neck/shoulder symptoms. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal preoperative VAS score threshold. Results: Residual neck/shoulder pain or stiffness was observed in 416 (68.0%) patients at 2 years postoperatively. Multivariable analysis demonstrated that women (OR 1.780, 95% CI 1.152–2.751; P =0.009), duration of neurological symptoms (OR 1.011, 95% CI 1.004–1.018; P =0.002), and preoperative neck/shoulder VAS scores (OR 1.231, 95% CI 1.114–1.360; P <0.001) were independently associated with residual symptoms. ROC analysis identified a preoperative VAS score of 60 mm as the optimal threshold for predicting residual symptoms (area under the curve, 0.653; sensitivity, 62.7%; specificity, 65.8%). Conclusions: Women, prolonged neurological symptom duration, and greater preoperative symptom severity were independently associated with persistent postoperative neck/shoulder symptoms. These findings may inform preoperative counseling regarding the likelihood of persistent neck/shoulder symptoms after surgery for DCM. Level of Evidence: II
- 1 September 2026
- Published by Wolters Kluwer Health in Spine
Predictors of Residual Neck/Shoulder Symptom Following Surgery for Degenerative Cervical Myelopathy
Study Design: Prospective multicenter cohort study. Objective: To determine the prevalence of residual neck/shoulder pain or stiffness after surgery for degenerative cervical myelopathy (DCM) and identify the factors associated with the persistence of these symptoms. Summary of Background Data: Neck/shoulder pain or stiffness is common in patients with DCM and may persist despite surgical treatment. However, the factors associated with the persistence of these symptoms remain unclear. Methods: A total of 612 patients with preoperative neck/shoulder pain or stiffness who underwent surgery for DCM were included in this study. Residual neck/shoulder symptoms were defined as a visual analog scale (VAS) score of > 30 mm at 2 years after surgery. Demographic characteristics, radiographic findings, surgical variables, neurological function, and patient-reported outcome measures were compared between patients with and without residual neck/shoulder symptoms. Binary logistic regression analysis was performed to identify the independent predictors of residual neck/shoulder symptoms. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal preoperative VAS score threshold. Results: Residual neck/shoulder pain or stiffness was observed in 416 (68.0%) patients at 2 years postoperatively. Multivariable analysis demonstrated that women (OR 1.780, 95% CI 1.152–2.751; P =0.009), duration of neurological symptoms (OR 1.011, 95% CI 1.004–1.018; P =0.002), and preoperative neck/shoulder VAS scores (OR 1.231, 95% CI 1.114–1.360; P <0.001) were independently associated with residual symptoms. ROC analysis identified a preoperative VAS score of 60 mm as the optimal threshold for predicting residual symptoms (area under the curve, 0.653; sensitivity, 62.7%; specificity, 65.8%). Conclusions: Women, prolonged neurological symptom duration, and greater preoperative symptom severity were independently associated with persistent postoperative neck/shoulder symptoms. These findings may inform preoperative counseling regarding the likelihood of persistent neck/shoulder symptoms after surgery for DCM. Level of Evidence: II
- Open Access
- 31 August 2026
- Published by SAGE Publications in Global Spine Journal
Discrepancy Between Clinician- and Patient-Reported Definitions of Mild Degenerative Cervical Myelopathy and Surgical Outcomes
Study Design: Prospective multicenter observational cohort study. Objective: To redefine mild degenerative cervical myelopathy (DCM) using a patient-reported severity framework derived from Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) and to compare surgical outcomes with the conventional clinician-reported definition. Methods: Patients with DCM undergoing surgery at 10 spine centers were enrolled. Mild DCM was defined using two criteria: a clinician-reported definition based on Japanese Orthopaedic Association (JOA) score (≧ 14.5) and a patient-reported definition derived from principal component analysis of JOACMEQ domains and Numerical Rating Scale (NRS) pain scores. Patients were categorized into four groups: Dual-Mild, Clinician-Mild, Patient-Mild, and Non-Mild. Postoperative outcomes were assessed using achievement of minimum clinically important difference (MCID) for JOA score, JOACMEQ, NRS, and Short Form-36 (SF-36). Multivariable logistic regression models were used to estimate adjusted probabilities of MCID achievement. Results: Among 930 eligible patients, 122 met criteria for mild DCM by each definition. Patients classified as Patient-Mild demonstrated higher baseline function and lower pain scores but showed significantly lower adjusted probabilities of achieving MCID in pain-related outcomes and SF-36 physical component summary (PCS) (odds ratio for PCS, 0.346 [0.196-0.589]; p < 0.001). In contrast, Clinician-Mild status was associated with sustained postoperative improvement. Conclusion: Definitions of mild DCM differ substantially between clinician- and patient-reported criteria. Patients who perceive their disease as mild exhibit limited postoperative improvement. Incorporating patient-reported severity into preoperative assessment may better inform expectations and shared decision-making regarding surgery in mild DCM.
- 31 August 2026
- Published by SAGE Publications in Global Spine Journal
Open AccessDiscrepancy Between Clinician- and Patient-Reported Definitions of Mild Degenerative Cervical Myelopathy and Surgical Outcomes
Study Design: Prospective multicenter observational cohort study. Objective: To redefine mild degenerative cervical myelopathy (DCM) using a patient-reported severity framework derived from Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) and to compare surgical outcomes with the conventional clinician-reported definition. Methods: Patients with DCM undergoing surgery at 10 spine centers were enrolled. Mild DCM was defined using two criteria: a clinician-reported definition based on Japanese Orthopaedic Association (JOA) score (≧ 14.5) and a patient-reported definition derived from principal component analysis of JOACMEQ domains and Numerical Rating Scale (NRS) pain scores. Patients were categorized into four groups: Dual-Mild, Clinician-Mild, Patient-Mild, and Non-Mild. Postoperative outcomes were assessed using achievement of minimum clinically important difference (MCID) for JOA score, JOACMEQ, NRS, and Short Form-36 (SF-36). Multivariable logistic regression models were used to estimate adjusted probabilities of MCID achievement. Results: Among 930 eligible patients, 122 met criteria for mild DCM by each definition. Patients classified as Patient-Mild demonstrated higher baseline function and lower pain scores but showed significantly lower adjusted probabilities of achieving MCID in pain-related outcomes and SF-36 physical component summary (PCS) (odds ratio for PCS, 0.346 [0.196-0.589]; p < 0.001). In contrast, Clinician-Mild status was associated with sustained postoperative improvement. Conclusion: Definitions of mild DCM differ substantially between clinician- and patient-reported criteria. Patients who perceive their disease as mild exhibit limited postoperative improvement. Incorporating patient-reported severity into preoperative assessment may better inform expectations and shared decision-making regarding surgery in mild DCM.
- Open Access
- 28 August 2026
- Published by SAGE Publications in Global Spine Journal
Impact of Concomitant Cervical Anterolisthesis on Surgical Outcomes in Cervical Spondylotic Myelopathy: A Multicenter Prospective Study
Study Design: Multicenter prospective cohort study. Objectives: This study aimed to determine whether concomitant cervical anterolisthesis influences surgical outcomes in patients with cervical spondylotic myelopathy (CSM). Methods: A total of 691 CSM patients were enrolled and classified into those with anterolisthesis ≥ 2 mm (Slip group, n=95) and those without measurable slip (Non-slip group, n=596). Patients underwent surgical treatment as indicated and were followed for 2 years. Cervical alignment, C2–7 ROM, JOA scores, JOACMEQ domains, and SF-36 scores were assessed. Clinical outcomes were compared using multivariate analyses adjusted for baseline factors. A subgroup analysis evaluated high-grade slip (≥4 mm). Results: The Slip group was older and had more kyphosis and worse baseline lordosis and JOA score. Fusion was performed more frequently in the Slip group, which also showed a greater reduction in cervical ROM at 2 years. Adjusted postoperative JOA score, JOACMEQ, and SF-36 outcomes were comparable between groups postoperatively. Within the Slip group, high-grade slip (≥4 mm) was associated with less JOA improvement in an exploratory subgroup analysis, whereas JOACMEQ and SF-36 scores were not influenced by slip severity. Conclusions: Neutral-radiograph-defined cervical anterolisthesis ≥2 mm was not independently associated with worse adjusted 2-year neurological, functional, or quality-of-life outcomes. High-grade slip (≥4 mm), however, may limit neurological recovery, underscoring the importance of evaluating segmental stability when substantial slippage is present.
- 28 August 2026
- Published by SAGE Publications in Global Spine Journal
Open AccessImpact of Concomitant Cervical Anterolisthesis on Surgical Outcomes in Cervical Spondylotic Myelopathy: A Multicenter Prospective Study
Study Design: Multicenter prospective cohort study. Objectives: This study aimed to determine whether concomitant cervical anterolisthesis influences surgical outcomes in patients with cervical spondylotic myelopathy (CSM). Methods: A total of 691 CSM patients were enrolled and classified into those with anterolisthesis ≥ 2 mm (Slip group, n=95) and those without measurable slip (Non-slip group, n=596). Patients underwent surgical treatment as indicated and were followed for 2 years. Cervical alignment, C2–7 ROM, JOA scores, JOACMEQ domains, and SF-36 scores were assessed. Clinical outcomes were compared using multivariate analyses adjusted for baseline factors. A subgroup analysis evaluated high-grade slip (≥4 mm). Results: The Slip group was older and had more kyphosis and worse baseline lordosis and JOA score. Fusion was performed more frequently in the Slip group, which also showed a greater reduction in cervical ROM at 2 years. Adjusted postoperative JOA score, JOACMEQ, and SF-36 outcomes were comparable between groups postoperatively. Within the Slip group, high-grade slip (≥4 mm) was associated with less JOA improvement in an exploratory subgroup analysis, whereas JOACMEQ and SF-36 scores were not influenced by slip severity. Conclusions: Neutral-radiograph-defined cervical anterolisthesis ≥2 mm was not independently associated with worse adjusted 2-year neurological, functional, or quality-of-life outcomes. High-grade slip (≥4 mm), however, may limit neurological recovery, underscoring the importance of evaluating segmental stability when substantial slippage is present.
- 18 August 2026
- Published by Springer Nature in Spinal Cord
- Vol. 64 (10) , 953-959
Surgical outcomes and age-related differences in cauda equina tumors assessed by patient-reported outcome measures using the Japanese orthopaedic association back pain evaluation questionnaire
Study design Single-institution retrospective study. Objectives To evaluate postoperative neurological and QOL outcomes in patients with cauda equina tumors using JOABPEQ, and to investigate age-related differences in postoperative recovery, which remain poorly understood in this population. Setting Single university hospital. Methods Sixty-five patients who underwent surgery for cauda equina tumors from 2008–2017 were retrospectively analyzed. Neurological function was assessed using the JOA score, and QOL was evaluated using JOABPEQ before surgery and at two years postoperatively. Pain and sensory symptoms were assessed using VAS scores. Patients were categorized into elderly (≥65 years) and non-elderly (<65 years) groups. General linear models and multivariable logistic regression analyses were performed. Results Significant postoperative improvements were observed in JOA score, VAS scores, and all JOABPEQ domains. JOABPEQ demonstrated relatively high effectiveness rates in pain-related and physical function domains, whereas mental health showed the lowest effectiveness rate. Improvement in lower-limb numbness was independently associated with better recovery in walking ability, social life function, and mental health. Elderly patients showed worse preoperative neurological and pain-related symptoms; however, postoperative outcomes and JOABPEQ effectiveness rates were comparable between elderly and non-elderly patients after adjustment for cardiovascular disease and baseline severity. Conclusion Surgical treatment for cauda equina tumors resulted in significant improvements in neurological function, pain, and QOL. Despite worse preoperative symptoms, elderly patients achieved postoperative outcomes comparable to those of non-elderly patients after adjustment for baseline factors. These findings support the usefulness of PROM-based evaluation in patients with cauda equina tumors.
- 18 August 2026
- Published by Springer Nature in Spinal Cord
- Vol. 64 (10) , 953-959
Surgical outcomes and age-related differences in cauda equina tumors assessed by patient-reported outcome measures using the Japanese orthopaedic association back pain evaluation questionnaire
Study design Single-institution retrospective study. Objectives To evaluate postoperative neurological and QOL outcomes in patients with cauda equina tumors using JOABPEQ, and to investigate age-related differences in postoperative recovery, which remain poorly understood in this population. Setting Single university hospital. Methods Sixty-five patients who underwent surgery for cauda equina tumors from 2008–2017 were retrospectively analyzed. Neurological function was assessed using the JOA score, and QOL was evaluated using JOABPEQ before surgery and at two years postoperatively. Pain and sensory symptoms were assessed using VAS scores. Patients were categorized into elderly (≥65 years) and non-elderly (<65 years) groups. General linear models and multivariable logistic regression analyses were performed. Results Significant postoperative improvements were observed in JOA score, VAS scores, and all JOABPEQ domains. JOABPEQ demonstrated relatively high effectiveness rates in pain-related and physical function domains, whereas mental health showed the lowest effectiveness rate. Improvement in lower-limb numbness was independently associated with better recovery in walking ability, social life function, and mental health. Elderly patients showed worse preoperative neurological and pain-related symptoms; however, postoperative outcomes and JOABPEQ effectiveness rates were comparable between elderly and non-elderly patients after adjustment for cardiovascular disease and baseline severity. Conclusion Surgical treatment for cauda equina tumors resulted in significant improvements in neurological function, pain, and QOL. Despite worse preoperative symptoms, elderly patients achieved postoperative outcomes comparable to those of non-elderly patients after adjustment for baseline factors. These findings support the usefulness of PROM-based evaluation in patients with cauda equina tumors.
- Open Access
- 17 August 2026
- Published by SAGE Publications in Global Spine Journal
Patterns of Neurological Recovery after Posterior Decompression Without Fusion for Degenerative Cervical Myelopathy According to the Timing of Minimum Clinically Important Difference Achievement
Study Design: Prospective cohort study. Objectives: The significance of failing to achieve the minimum clinically important difference (MCID) early after surgery for degenerative cervical myelopathy (DCM) remains unclear. To compare postoperative clinical outcomes among early-, delayed-, and persistent non-responders for DCM and to clarify the clinical significance of delayed neurological recovery. Methods: A total of 655 patients with moderate-to-severe DCM were categorized according to the achievement of the MCID in the Japanese Orthopaedic Association (JOA) score: early responders (MCID at 6 months), delayed responders (no MCID at 6 months but MCID at 2 years), and persistent non-responders (no MCID at either time point). Neurological, pain-related, and patient-reported outcomes were compared among the groups. Among patients without MCID achievement at 6 months, binary logistic regression analysis was performed to identify the factors associated with delayed MCID achievement. Results: Among patients without MCID achievement at 6 months, 36.9% achieved the MCID by 2 years. Binary logistic regression identified the 6-month JOA score, upper extremity function in the JOA Cervical Myelopathy Evaluation Questionnaire, and physical component summary of the 36-Item Short Form Health Survey as associated factors. Pain-related measures, autonomic function, and mental health status did not differ significantly among the groups. Conclusions: Approximately one-third of patients without early MCID achievement subsequently achieved the MCID within 2 years. Failure to achieve the MCID at 6 months does not necessarily indicate poor long-term outcomes, supporting the importance of continued postoperative follow-up.
- 17 August 2026
- Published by SAGE Publications in Global Spine Journal
Open AccessPatterns of Neurological Recovery after Posterior Decompression Without Fusion for Degenerative Cervical Myelopathy According to the Timing of Minimum Clinically Important Difference Achievement
Study Design: Prospective cohort study. Objectives: The significance of failing to achieve the minimum clinically important difference (MCID) early after surgery for degenerative cervical myelopathy (DCM) remains unclear. To compare postoperative clinical outcomes among early-, delayed-, and persistent non-responders for DCM and to clarify the clinical significance of delayed neurological recovery. Methods: A total of 655 patients with moderate-to-severe DCM were categorized according to the achievement of the MCID in the Japanese Orthopaedic Association (JOA) score: early responders (MCID at 6 months), delayed responders (no MCID at 6 months but MCID at 2 years), and persistent non-responders (no MCID at either time point). Neurological, pain-related, and patient-reported outcomes were compared among the groups. Among patients without MCID achievement at 6 months, binary logistic regression analysis was performed to identify the factors associated with delayed MCID achievement. Results: Among patients without MCID achievement at 6 months, 36.9% achieved the MCID by 2 years. Binary logistic regression identified the 6-month JOA score, upper extremity function in the JOA Cervical Myelopathy Evaluation Questionnaire, and physical component summary of the 36-Item Short Form Health Survey as associated factors. Pain-related measures, autonomic function, and mental health status did not differ significantly among the groups. Conclusions: Approximately one-third of patients without early MCID achievement subsequently achieved the MCID within 2 years. Failure to achieve the MCID at 6 months does not necessarily indicate poor long-term outcomes, supporting the importance of continued postoperative follow-up.
- 13 August 2026
- Published by Wolters Kluwer Health in Spine
Response to the Letter Regarding “Influence of Preoperative Mental Health on Surgical and Clinical Outcomes in Degenerative Cervical Myelopathy”
Was not provided for this article.
- 13 August 2026
- Published by Wolters Kluwer Health in Spine
Response to the Letter Regarding “Influence of Preoperative Mental Health on Surgical and Clinical Outcomes in Degenerative Cervical Myelopathy”
Was not provided for this article.